Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of a Meningococcal Serogroup B Vaccine in Adult Patients with Asplenia

NCT06025487 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06025487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of a Meningococcal Serogroup B Vaccine in Adult Patients with Asplenia
Lead sponsor
Medical University of Vienna
Phase
Phase 2
Overall status
Recruiting
Start date
March 12, 2024
Completion date
December 31, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

splenectomy; status